Worldwide incidence is about 3 per 1000, including all cell types.
Adenocarcinoma usually occurs in the lower half of the esophagus.
Most squamous cell cancers are poylpoid and project into the esophageal lumen.
Less than 10% of all esophageal cancers are adenocarcinomas.
Gastroesophageal junction tumors rarely spread to mediastinal nodes.
Question 2: Which of the following statements is true regarding the medical management of esophageal cancer?
Cineesophagograms typically show annular narrowing with marked proximal dilitation.
Radical radiation therapy has consistently produced survival near 20% at 5 years.
Systemic chemotherapy can produce up to 50% response rates, but improvement is short-term.
Combining chemotherapy, radiation, and surgery increases survival but does not increase resectability.
Question 3: Which of the following statements is true regarding the results after surgical treatment of esophageal cancer?
Esophagogastrectomy with esophagogastrostomy is best used for cervical lesions, as the gastroesophageal junction is preserved.
Esophagogastrectomy with colon interposition has equivalent hospital mortality to esophagogastrectomy with esophagogastrostomy.
Five-year survival with surgical resection is about 20%.
Surgical esophageal bypass produces better palliation than endoscopic techniques.